Stockholm - Free Realtime Quote SEK

Fluicell AB (publ) (FLUI.ST)

Compare

0.0720

-0.0016

(-2.17%)

As of 9:24 AM GMT+2. Market Open.

Currency in SEK All numbers in thousands

Download

Breakdown

TTM

12/31/2023

12/31/2022

12/31/2021

12/31/2020

12/31/2019

Total Revenue

1,297.0000

3,338.0000

3,251.0000

2,602.0000

4,635.0000

Cost of Revenue

1,527.0000

1,600.0000

663.0000

715.0000

988.0000

Gross Profit

-230.0000

1,738.0000

2,588.0000

1,887.0000

3,647.0000

Operating Expense

26,900.0000

28,617.0000

24,314.0000

23,582.0000

20,673.0000

Operating Income

-27,130.0000

-26,879.0000

-21,726.0000

-21,695.0000

-17,026.0000

Net Non Operating Interest Income Expense

485.0000

849.0000

311.0000

2.0000

-564.0000

Pretax Income

-27,170.0000

-26,554.0000

-21,606.0000

-21,693.0000

-17,590.0000

Net Income Common Stockholders

-27,170.0000

-26,554.0000

-21,606.0000

-21,693.0000

-17,590.0000

Diluted NI Available to Com Stockholders

-27,170.0000

-26,554.0000

-21,606.0000

-21,693.0000

-17,590.0000

Basic EPS

0.20

-0.23

-0.21

-0.38

-0.31

Diluted EPS

0.20

-0.23

-0.21

-0.38

-0.31

Basic Average Shares

455,118.9020

117,042.1550

105,320.5990

57,606.2710

Diluted Average Shares

455,118.9020

117,042.1550

105,320.5990

57,606.2710

Total Operating Income as Reported

-27,131.0000

-26,879.0000

-21,726.0000

-21,695.0000

-17,026.0000

Total Expenses

28,427.0000

30,217.0000

24,977.0000

24,297.0000

21,661.0000

Net Income from Continuing & Discontinued Operation

-27,170.0000

-26,554.0000

-21,606.0000

-21,693.0000

-17,590.0000

Normalized Income

-27,170.0000

-26,554.0000

-21,606.0000

-21,693.0000

-17,590.0000

Interest Income

506.0000

879.0000

358.0000

29.0000

Interest Expense

21.0000

30.0000

47.0000

27.0000

564.0000

Net Interest Income

485.0000

849.0000

311.0000

2.0000

-564.0000

EBIT

-27,149.0000

-26,524.0000

-21,559.0000

-21,666.0000

-17,026.0000

EBITDA

-26,661.0000

-25,914.0000

-20,839.0000

-21,078.0000

-16,421.0000

Reconciled Cost of Revenue

1,527.0000

1,600.0000

663.0000

715.0000

988.0000

Reconciled Depreciation

488.0000

610.0000

720.0000

588.0000

605.0000

Net Income from Continuing Operation Net Minority Interest

-27,170.0000

-26,554.0000

-21,606.0000

-21,693.0000

-17,590.0000

Normalized EBITDA

-26,661.0000

-25,914.0000

-20,839.0000

-21,078.0000

-16,421.0000

12/31/2019 - 4/18/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

COMBI.ST CombiGene AB (publ)

2.4600

0.00%

LPGO.ST Lipigon Pharmaceuticals AB (publ)

0.1800

-2.17%

ACE.ST Ascelia Pharma AB (publ)

2.2400

+1.59%

ISOFOL.ST Isofol Medical AB (publ)

3.6250

-8.23%

9RP.F Lipigon Pharmaceuticals AB (publ)

0.0010

-16.67%

RESP.ST Respiratorius AB

0.0578

0.00%

ACTI.ST Active Biotech AB (publ)

0.2895

-1.70%

WNT.ST WntResearch AB

0.9000

0.00%

SPRINT.ST Sprint Bioscience AB (publ)

1.7800

0.00%

ELIC.ST Elicera Therapeutics AB (publ)

1.5550

+1.63%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Fluicell AB (publ) (FLUI.ST)

Upgrade to begin using 40 years of financial statements and get so much more.

Related Tickers